ERIS.NS
ERIS.NS
INE406M01024
ERIS LIFESCIENCES LIMITED
Loading chart...

Company Profile

Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women's health, GLP-1, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram monitoring, continuous glucose monitoring system, sleep device, antenatal care, and early neuropathy screening solutions, as well as polycystic ovary syndrome screening, diagnosis, and management. The company offers its products through wholesale drug distributors, stockists, retail and e-commerce pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is headquartered in Ahmedabad, India.

Related stocks

ALIVUS.NS
ALIVUS.NS • India
ALIVUS LIFE SCIENCES LTD
1,326.3 INR
1.68B USD 1Y +45.4%
NATCOPHARM.NS
NATCOPHARM.NS • India
NATCO PHARMA LTD.
789.4 INR
1.5B USD 1Y -1.7%
ASTRAZEN.BO
ASTRAZEN.BO • India
ASTRAZENECA PHARMA INDIA LTD.
5,831.85 INR
1.51B USD 1Y -38.5%
GRANULES.NS
GRANULES.NS • India
GRANULES INDIA LIMITED
815.25 INR
2.3B USD 1Y +48.5%
APLLTD.NS
APLLTD.NS • India
ALEMBIC PHARMA LTD
800.95 INR
1.63B USD 1Y -14%
SHILPAMED.BO
SHILPAMED.BO • India
SHILPA MEDICARE LTD.
1,020.35 INR
2.06B USD 1Y +187.4%
CAPLIPOINT.BO
CAPLIPOINT.BO • India
CAPLIN POINT LABORATORIES LTD.
2,459.55 INR
1.93B USD 1Y +27.1%
EMCURE.NS
EMCURE.NS • India
EMCURE PHARMACEUTICALS L
1,833.5 INR
3.59B USD 1Y +31.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
28.5% p.a.
Max Drawdown (5Y)
-38.0%
Sharpe Ratio (5Y)
0.19
Beta Factor
-0.03
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (28.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -56.2% in the extended horizon.
ende